June 2024

OpTiMus: A Novel Transgenic Mouse Platform for Discovery of Fully Human Therapeutic-Grade TCRs and Generation of Bispecific T Cell Engagers

This presentation has been presented at: 5th Annual TCR-Based Therapies for Solid Tumours Summit, Boston on 24th March 2024 by E-Chiang Lee (Ex VP Research) Immuno-Oncology Summit, Europe on 25th March 2024 by Wei Wang (Snr Director of Technology) Download/View Share Share Tweet...

Content Team In Insights

David Hung Joins T-Therapeutics

Dr David Hung has joined T-Therapeutics as Chairman of its Board of Directors. In this video, which accompanied the announcement, Dr Hung explains his decision: “I have always wanted to be on the cutting-edge of science and transform the practice of medicine. I...

Content Team In Press Release

T-Therapeutics appoints Dr David Hung as Chairman

Industry veteran, founder of Medivation and serial entrepreneur joins T-Therapeutics to support development of the company’s pipeline of TCR-based immuno-oncology drugs 12 June 2024; Cambridge, England – T-Therapeutics, a biotechnology company developing next-generation soluble TCR therapeutics targeting cancer and autoimmune indications, today announces...

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

OpTiMus: A Novel Transgenic Mouse Platform for Discovery of Fully Human Therapeutic-Grade TCRs and Generation of Bispecific T Cell Engagers

David Hung Joins T-Therapeutics

T-Therapeutics appoints Dr David Hung as Chairman

Recent Posts